Everise, a leading customer experience (CX) solutions provider, today unveiled a strategic partnership with Krisp, deploying ...

Actym Therapeutics, a clinical-stage therapeutic product development and platform company, today announced the issuance of US patent Nos. 12,201,653 and 12,226,439 by the United States Patent and ...

The global biosimilars market growth is driven by increasing number of biosimilar approvals and rising number of biologics going off-patent.A biosimilar is a biological product that is similar to a ...

New licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist in advanced stages of clinical development in China. Phase 2 data suggest ...

Guggenheim Securities is serving as financial advisor to atai and Latham & Watkins LLP is serving as its legal counsel.

Partner Charlie Henn reveals some of the firm’s key achievements from 2024 and explains how the firm takes advantage of its ...

The acquisition includes a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved in the US and the EU, and a promising advanced and early-stage immunology pipeline. Furthermore, ...